The Eisai Assistance Program can provide information to patients and healthcare professionals about coverage for BELVIQ® or BELVIQ XR® and programs to help patients afford their medication. Depending on your financial situation and clinical status, resources may be available to help with your costs for BELVIQ®.
The Eisai Assistance Program can also provide information about the Patient Assistance Program for BELVIQ® which provides support to customers who need assistance paying for BELVIQ®. This program provides BELVIQ® at no cost to financially needy patients who meet program eligibility criteria. BELVIQ XR® is not available through the Patient Assistance Program at this time.
1. If your commercial insurance covers BELVIQ® or
BELVIQ XR®, simply use the card to Save Up to $160 on every 30
2. If you don’t have commercial coverage for BELVIQ® or BELVIQ XR®, or if you pay cash for your prescription or have Medicare Part D, we can help! Use the card to Save Up to $185 on every 30 day supply**
Get your savings card by clicking here. If you have any questions about the program rules or require additional information, please call 1-855-BELVIQ1 (tel: 1-855-235-8471) (8:00AM - 11:00 PM ET Monday - Friday)
* Not available to patients who are eligible for state or federal healthcare programs. Please refer to complete Restrictions and Conditions of Use below.
**Out of Pocket Costs, for saving card users, on average for Commercial coverage are ≤ $35 or less. If you have not reached your plan deductible, out of pocket costs may be higher. For Cash pay, average out of pocket costs are ≤ $95 based on McKesson Cost/Coverage data 2015.
If you have any questions about the program rules or require additional information, please call 1-855-BELVIQ1 (1-855-235-8471).
Eisai has created the Assistance Program for BELVIQ® for customers who need assistance paying for BELVIQ®. This program provides BELVIQ® at low cost to financially needy patients who meet program eligibility criteria. Patients can call the Patient Assistance Program for BELVIQ® at 1-866-61-EISAI (1-866-613-4724) to determine eligibility. The hours of operation are Monday through Friday, 8am to 8pm ET. BELVIQ XR® is not available through the Patient Assistance Program at this time.
Eisai reserves the right, at its sole discretion, to discontinue the Patient Assistance Program or change the qualifications at any time. All patient information remains confidential. Product supply for the program depends upon availability
Eisai cannot guarantee payment of any claim. Coding, coverage, and reimbursement may vary significantly by payor, plan, patient, and setting of care. Actual coverage and reimbursement decisions are made by individual payors following the receipt of claims. For additional information, customers should consult with their payors for all relevant coding, reimbursement, and coverage requirements. It is the sole responsibility of the provider to select the proper code and ensure the accuracy of all claims used in seeking reimbursement. All services must be medically appropriate and properly supported in the patient medical record
BELVIQ® and BELVIQ XR® are FDA-approved prescription weight-loss medications that, when used with diet and exercise, can help some overweight (Body Mass Index [BMI] ≥27 kg/m²) adults with a weight-related medical problem, or obese (BMI ≥30 kg/m²) adults, lose weight and keep it off.
It is not known if BELVIQ or BELVIQ XR when taken with other prescription, over-the-counter, or herbal weight-loss products is safe and effective. It is not known if BELVIQ or BELVIQ XR changes your risk of heart problems, stroke, or death due to heart problems or stroke.
BELVIQ and BELVIQ XR are federally controlled substances (CIV) because they may be abused or lead to drug dependence.
You are encouraged to report negative side effects of prescription drugs to the FDA.
The information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare professional. All decisions regarding patient care must be made with a healthcare professional, considering the unique characteristics of the patient.
This site is intended for residents of the United States only. Any products discussed herein may have different product labeling in different countries.
BELVIQ® and BELVIQ XR® are registered trademarks of Arena Pharmaceuticals GmbH.